Double Bond Pharmaceutical International AB - Class B

NEW
XSAT:DBP B (Sweden)   B
kr 0.13 +0.0070 (+5.58%) Jul 17
At Loss
P/B:
1.95
Market Cap:
kr 29.53M ($ 3.06M)
Enterprise V:
kr 28.46M ($ 2.95M)
Volume:
131.59K
Avg Vol (2M):
278.78K
Trade In:
Volume:
131.59K
At Loss
Avg Vol (2M):
278.78K

Business Description

Double Bond Pharmaceutical International AB

ISIN : SE0007185525

Share Class Description:

XSAT:DBP B: B

Total Employee Number:

8
Description
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.85
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
6.38
Distress
Grey
Safe
Beneish M-Score
18.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year FCF Growth Rate
49.3
3-Year Book Growth Rate
-24.4
Name Current Vs Industry Vs History
5-Day RSI
52.64
9-Day RSI
53.89
14-Day RSI
53.43
3-1 Month Momentum %
-14.53
6-1 Month Momentum %
-5
12-1 Month Momentum %
-7.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.83
Quick Ratio
0.83
Cash Ratio
0.43
Days Sales Outstanding
212.07

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-39.7

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
3256.93
Operating Margin %
-1140.15
Net Margin %
366.42
EBITDA Margin %
523.36
FCF Margin %
-3429.2
OCF Margin %
-3429.2
ROE %
5.58
ROA %
3.57
ROIC %
-9.79
3-Year ROIIC %
391.37
ROC (Joel Greenblatt) %
1523.68
ROCE %
6.43

Financials (Next Earnings Date:2026-08-27)

XSAT:DBP B's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Double Bond Pharmaceutical International AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 0.137
EPS (TTM) (kr) -0.01
Beta 2.1947
3-Year Sharpe Ratio 0.08
3-Year Sortino Ratio 0.15
Volatility % 89.36
14-Day RSI 53.43
14-Day ATR (kr) 0.013612
20-Day SMA (kr) 0.12645
12-1 Month Momentum % -7.49
52-Week Range (kr) 0.09 - 0.268
Shares Outstanding (Mil) 222.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Double Bond Pharmaceutical International AB Filings

Filing Date Document Date Form
No Filing Data

Double Bond Pharmaceutical International AB Stock Events

Financials Calendars
Event Date Price (kr)
Third quarter earnings results for 2026 2026-11-13 In 116 days
Second quarter earnings results for 2026 2026-08-27 In 38 days
First quarter earnings results for 2026 2026-05-22 0.12 (-7.48%)
General meeting for 2026 2026-04-23 13:00 0.14 (+0.00%)
Annual report for 2025 2026-03-26 0.12 (+0.00%)
Fourth quarter earnings results for 2025 2026-02-26 0.12 (+2.21%)
Third quarter earnings results for 2025 2025-11-14 0.11 (+0.00%)
Second quarter earnings results for 2025 2025-08-26 0.13 (-6.69%)
First quarter earnings results for 2025 2025-05-23 0.32 (-5.87%)
Annual report for 2024 2025-05-22 0.34 (+6.25%)
Show
Entries

Double Bond Pharmaceutical International AB Frequently Asked Questions

What is Double Bond Pharmaceutical International AB(XSAT:DBP B)'s stock price today?
The current price of XSAT:DBP B is kr0.13. The 52 week high of XSAT:DBP B is kr0.27 and 52 week low is kr0.09.
When is next earnings date of Double Bond Pharmaceutical International AB(XSAT:DBP B)?
The next earnings date of Double Bond Pharmaceutical International AB(XSAT:DBP B) is 2026-08-27.
Does Double Bond Pharmaceutical International AB(XSAT:DBP B) pay dividends? If so, how much?
Double Bond Pharmaceutical International AB(XSAT:DBP B) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Double Bond Pharmaceutical International AB

No articles.